Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Hematology Therapeutics Market Research Reports

Titlepublishedprice

China Heparin Sodium Market Research Report 2017

By QYResearch Group
"...... anufacturer, covering - Shenzhen Hepalink - Bioibérica - Nanjing King-friend - Pfizer - SPL - Dongcheng Biochemicals - Changzhou Qianhong Bio-pharma - Changshan Biochemical - Pharma Actio......"
12-Jan-2017$3200

Europe Heparin Sodium Market Report 2017

By QYResearch Group
"...... s in these countries, with sales, price, revenue and market share for each player in these Countries, covering - - Shenzhen Hepalink - - Bioibérica - - Nanjing King-friend - - Pfizer - - SPL - - Dongcheng Bio......"
11-Jan-2017$3900

Septicaemia-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Hyperkalemia-Pipeline Insights, 2017

By Delve Insight
"...... ase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations detail......"
01-Jan-2017$1250

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... globe. A key objective of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Report is to understand the market and pipeline status of the drugs around the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)......"
01-Jan-2017$2000

Bacteremia-Pipeline Insights, 2017

By Delve Insight
"...... I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. D......"
01-Jan-2017$1250

Thromboembolism-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Thrombosis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... to understand the market and pipeline status of the drugs around the Hypercalcemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report......"
01-Jan-2017$2000

Hypercholesterolemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... mia Report is to understand the market and pipeline status of the drugs around the Hypercholesterolemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The ......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.